Skip to Content

Ontrak Inc HY10

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HY10 is trading at a 511% premium.
Price
€0.33
Fair Value
€8.35
Uncertainty
Extreme
1-Star Price
€6.84
5-Star Price
€1.76
Economic Moat
Sjnks
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HY10 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.14
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Value
Total Number of Employees
104

Valuation

Metric
HY10
Price/Earnings (Normalized)
Price/Book Value
2.31
Price/Sales
0.14
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
HY10
Quick Ratio
1.85
Current Ratio
2.54
Interest Coverage
−3.03
Quick Ratio
HY10

Profitability

Metric
HY10
Return on Assets (Normalized)
−130.65%
Return on Equity (Normalized)
−391.94%
Return on Invested Capital (Normalized)
−153.43%
Return on Assets
HY10
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GE HealthCare Technologies Inc Common Stock
GEHC
Jtjxfk$34.9 Bil
Veeva Systems Inc Class A
VEEV
JhqzyrkwrFtwl$29.9 Bil
Solventum Corp
SOLV
Skms$9.4 Bil
Pro Medicus Ltd
PMCUF
Bkdpy$9.1 Bil
HealthEquity Inc
HQY
Qcwzw$7.2 Bil
Tempus AI Inc Class A common stock
TEM
Lhv$6.6 Bil
M3 Inc
MTHRF
Dnzck$6.5 Bil
M3 Inc ADR
MTHRY
Mhzxp$6.5 Bil
Doximity Inc Class A
DOCS
Bchvhtb$5.5 Bil
R1 RCM Inc
RCM
Ddzxj$5.3 Bil

Sponsor Center